Short Interest in Exicure, Inc. (NASDAQ:XCUR) Drops By 17.3%

Exicure, Inc. (NASDAQ:XCUR) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 50,600 shares, a drop of 17.3% from the December 31st total of 61,200 shares. Currently, 21.5% of the company’s stock are sold short. Based on an average daily volume of 727,200 shares, the days-to-cover ratio is currently 0.1 days.

Exicure Stock Performance

NASDAQ XCUR opened at $11.23 on Friday. The stock has a market capitalization of $29.27 million, a PE ratio of -5.43 and a beta of 3.81. The stock has a 50-day simple moving average of $16.24 and a 200 day simple moving average of $7.01. Exicure has a twelve month low of $1.44 and a twelve month high of $36.00.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.